Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Novel SYK inhibitor shows potential as asthma therapeutic

March 7, 2012

New Taisho drug has promising pharmacological profile

March 7, 2012

Icatibant acetate may improve acquired angioedema

March 7, 2012

Canadian study reveals new potential tool for prostate cancer diagnosis

March 6, 2012

Phase II AMG-853 trial does not meet primary endpoint

March 6, 2012

German study reveals new prognostic marker for penile cancer

March 5, 2012

New calcium-activated potassium channel blocker shows potential in IBD model

March 2, 2012

New marker and potential therapeutic target identified for castration-resistant prostate cancer

March 1, 2012

Potassium channel blocker has antiobesity effects in animal models

March 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...